Release Date: 02/02/12 13:32 Summary: Earnings Guidance for H1 FY2012 Price Sensitive: Yes Download Document 377.12KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%